[Evaluation of the effectiveness of methylprednisolone sodium succinate in reducing the infarct area].
D000328:Adult; D000368:Aged; D003402:Creatine Kinase / Q000097:blood; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*
D008776:Methylprednisolone Hemisuccinate; D003402:Creatine Kinase; D008775:Methylprednisolone
Valutazione dell'efficacia del metilprednisolone sodiosuccinato nella riduzione dell'area infartuale.